Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/1998
10/22/1998CA2286789A1 Compounds
10/22/1998CA2286692A1 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998CA2286592A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998CA2286478A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998CA2286332A1 Inhibitors for urokinase receptor
10/22/1998CA2285601A1 Protease inhibitors
10/22/1998CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/21/1998EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998EP0872247A1 Pharmaceutical formulation
10/21/1998EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/21/1998EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
10/21/1998EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
10/21/1998EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins
10/21/1998EP0871644A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods
10/21/1998EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998EP0871622A1 Novel compounds
10/21/1998EP0871606A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
10/21/1998EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions
10/21/1998EP0871478A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
10/21/1998EP0871473A1 Pharmaceutical composition containing il-10
10/21/1998EP0871470A1 Haemopoietic growth factor antagonists and uses therefor
10/21/1998EP0871466A1 Method for the treatment or prevention of eczema/dermatitis
10/21/1998EP0871460A1 Bioactive factors of aloe vera plants
10/21/1998EP0871444A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
10/21/1998EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
10/21/1998EP0739351A4 Monomeric diols and phosphate linked oligomers formed therefrom
10/21/1998EP0710227B1 Vitamin d analogues
10/21/1998EP0579769B1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents
10/21/1998CN1196734A Anti-inflammatory agent
10/21/1998CN1196731A Diglycosylated 1,2-diols as mimetics of sialyl-lewis X and sialyl-Lewis A analogies
10/21/1998CN1196729A Novel heterocyclic compounds
10/21/1998CN1196720A Novel vitamin D analogues
10/21/1998CN1196678A Di-and trivalent small molecule selecting protein inhibitors
10/21/1998CN1196251A Medicinal liquor for treating rheumatoid disease and preparation technology thereof
10/21/1998CN1040327C Pyrido [2,3-d) pyrimidine-2,4-(1H, 3H)-diones and -2(1H,3H)-ones, manufacture method and use thereof
10/20/1998US5824771 Cyclic corticotropin-releasing factor peptides
10/20/1998US5824696 Medicaments
10/20/1998US5824686 Method of treating androgenic alopecia with 5-alpha reductase inhibitors
10/20/1998US5824678 Morpholine derivatives and their use as therapeutic agents
10/20/1998US5824673 Pharmaceutical compositions comprising metal complexes
10/20/1998US5824670 17-deoxycorticosteroid-21- O!carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
10/20/1998US5824661 Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
10/20/1998US5824645 Method of treating inflammation
10/20/1998US5824305 Bromelain protease of amino acid sequences as bactericides,anticarcinogenic agents, antiinflammatory agents or atherosclerosis
10/20/1998US5824303 Dna sequence encoding, proteins and peptides
10/15/1998WO1998045712A2 20 human secreted proteins
10/15/1998WO1998045439A1 Human tumor-associated membrane protein
10/15/1998WO1998045309A1 Novel phosphate compounds and their use as medicaments
10/15/1998WO1998045294A1 Compounds
10/15/1998WO1998045275A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998WO1998045268A1 Nicotinamide derivatives
10/15/1998WO1998044925A1 Calcilytic compounds
10/15/1998WO1998022500A3 Modulation of interactions between myosin and integrins
10/15/1998CA2286390A1 Human tumor-associated membrane protein
10/15/1998CA2286303A1 20 human secreted proteins
10/15/1998CA2285556A1 Calcilytic compounds
10/15/1998CA2285454A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998CA2285388A1 Compounds
10/15/1998CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998EP0870825A1 Human protein kinases hYAK3
10/14/1998EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/14/1998EP0870761A1 Thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
10/14/1998EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
10/14/1998EP0870019A2 Cell activation process and reagents therefor
10/14/1998EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998EP0869965A1 Steroid nitrite ester derivatives useful as anti-inflammatory drugs
10/14/1998EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/14/1998EP0869954A1 Novel heterocyclic compounds
10/14/1998EP0869947A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/14/1998EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis
10/14/1998EP0869941A1 Modified polyunsaturated fatty acids
10/14/1998EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998EP0869787A1 Vitronectin receptor antagonists
10/14/1998EP0869783A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
10/14/1998EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998EP0869781A1 Transdermal device for the delivery of flurbiprofen
10/14/1998EP0755380B1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same
10/14/1998EP0741743B1 Cyclic neurokinin a antagonists
10/14/1998EP0673366B1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
10/14/1998EP0543861B1 Imidazopyridine derivatives, process for their preparation and their application
10/14/1998CN1196057A Substituted phosphinic compounds and their use as pharmaceuticals
10/14/1998CN1195986A Paroxetine controlled release compositions
10/14/1998CN1195524A Pharmaceutical formulation
10/14/1998CN1195523A 组合物 The composition
10/14/1998CN1040211C Matrix metalloprotease inhibitors
10/13/1998US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles
10/13/1998US5821336 Polypeptide having specified amino acid sequence or fragment thereof
10/13/1998US5821332 Isolated receptor polypeptide having specified amino acid sequence; modulating immune response
10/13/1998US5821267 Modulating the inducible isoform over the constitutive; hypertensive, antiarthritic and diabetic agents; therapy with cytokines; toxic and septic shock
10/13/1998US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion
10/13/1998US5821262 Hydroxamic acid derivatives as inhibitors of cytokine production
10/13/1998US5821256 Endothelin receptor antagonists
10/13/1998US5821250 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/13/1998US5821248 Substance p antagonists
10/13/1998US5821231 Treatment of immunoinflammatory conditions
10/13/1998US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998US5821123 Modified antibody variable domains
1 ... 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 ... 1272